08.11.2019

Meet us at COMPAMED at Booth H19.4!

Like every year we are in Düsseldorf at the Compamed, which will take place from 18 November to 21 November. Here we present our products for neuroscientific research, especially the Brain Interchange Technology as well as our services for industry.

Visit us at booth H19.4 in hall 8a!

 

More Information about Compamed 2019

07.11.2019

Strüngmann Group invests in further expansion of CorTec

Today CorTec announced the close of a €13 million funding. The investor consortium is led by Santo Venture Capital, the Strüngmann family holding company. Alongside LBBW Venture Capital, several existing shareholders participate in the funding round. Based on the investments, CorTec plans the next step of expansion with a subsidiary in the USA and the development of the next generation of the Brain Interchange Technology.

Weiterlesen

16.10.2019

Closed-Loop Therapies: Development, Successes, Challenges

In research, the closed-loop approach is regarded as a promising method for achieving further progress in neurotherapy. CorTec launches a series of articles presenting the research and development of therapies based on closed loop, previous successes as well as upcoming challenges.

Closed loop means an adaptation of the therapeutic stimulation to the acute treatment needs of the patient. According to recent research results, existing neurotherapies, for example for Parkinson’s disease, can benefit from an adaptive treatment approach just as much as new therapies can become possible.

Learn about the background of the closed-loop approach

15.10.2019

Meet Us at SfN at booth no. 1642!

As every year we are exhibiting at the world’s largest neuroscience meeting organized by the Society for Neuroscience which is held in in Chicago this year.

We are presenting new electrode designs alongside our well-known products for recording and stimulation in the central as well as in the peripheral nervous system. Visit us at booth no. 1642 to also get the latest update on our Brain Interchange ONE closed-loop implant system.

Learn more about the SfN meeting

25.09.2019

Get to Know Us Better: CorTec Stories

We have created a completely new section on our website where we give you a comprehensive insight into our daily work, innovations in our products and technologies as well as into interesting facts about CorTec.

In regular intervals we are going to publish new articles, photos and videos there and we hope that you will enjoy following the history of our further development.

Check out the first stories that are already published and come back soon to find some more..

03.07.2019

Reason to Celebrate – CorTec received TOP 100 Award

On the evening of 28 June 2019, CEO, Dr. Jörn Rickert and Dr. Christina Schwartz received CorTec’s “TOP 100” award at the Jahrhunderthalle in Frankfurt. CorTec was ranked among the 10 best companies.

For the 26th time, the most innovative companies in Germany were honoured. On the basis of scientific systematics, TOP 100 evaluates the innovation management of medium-sized companies.

 

We are very pleased about the award and the confidence in our innovative strength.

Special thanks go to our strong team for the outstanding achievements that made this award possible.

 

Find out more about TOP 100 and the selection process here.

07.05.2019

CorTec Receives Freiburg Innovation Award

As one of five companies, CorTec was awarded the Freiburg Innovation Prize by the Technology Foundation Bio-Med Freiburg.

Bio-Med Freiburg has been awarding the prize every two years since 1992 in cooperation with the medical technology company Stryker and the bank Sparkasse Freiburg-Nördlicher Breisgau. The companies that received the award in this year’s edition are active in the fields of medical technology, chemistry, software and green energy.

20.03.2019

First CorTec Product Receives FDA Clearance

The °AirRay Cortical Electrode is CorTec’s first medical device to receive market clearance from the Food and Drug Administration (FDA) in the USA for invasive neuromonitoring in the central nervous system. It can now be used as a diagnostic aid, for example before brain surgery.

“For us as a company, the market clearance of our AirRay electrodes is an important milestone,” said Dr. Jörn Rickert, Chief Executive Officer of CorTec. “lt shows to us and to our customers that we have been working in the right direction. Together with our new premises, including our own production facility we are now ideally positioned as a partner for the development of innovative neurotherapies.”

Some brain diseases may require surgical resection of the affected parts of the brain. AirRay Cortical Electrode is used for invasive neuromonitoring which comprises recording and stimulation of brain activity from the cortical surface over a period of time. In order to precisely locate diseased brain tissue such as epileptogenic foci or brain tumors while protecting healthy areas responsible for important brain functions, the brain must be ‘mapped’ prior to surgery. The electrode may be used for up to 29 days.

CorTec introduces several innovations into this long-established method of treatment. The planar grid and strip electrodes are produced in a proprietary laser-assisted manufacturing process. This results in a very soft, thin, and flexible electrode that adapts well to the curved surface of the brain.

In combination with new analytical methods AirRay Cortical Electrode may enable shorter surgery durations and more precise diagnostics in the future: For example with the aid of automated mapping of the brain in real-time, as enabled by the CortiQ system from g.tec (Austria), it will be possible to locate functional brain areas faster and more reliably in the future.  A research group led by Nuri F. lnce at the University of Houston, Texas, is investigating high-frequency oscillations in brain activity as biomarkers for a more precise determination of epileptogenic foci. “Regulatory approval of CorTec’s AirRay Cortical Electrode opens up exciting new options both in clinical applications and in research using intracranial recording and stimulation methods,” commented neuroscientist Dr. Gerwin Schalk, Chair of the International Workshop on Advances in Electrocorticography series and Deputy Director of the National Center for Adaptive Neurotechnologies in Albany.

The product also contains important safety features. “Health and well-being of the patient are of the utmost importance to us. Therefore, we emphasize safe electrode design,” said Dr. Martin Schüttler, Chief Technology Officer and also Chief Executive Officer of CorTec. °AirRay Cortical Electrode has an even surface with individual electrode contacts almost being impalpable. Additionally, to prevent the contacts from dislocating or detaching from the silicone carrier material each contact safely interlocks with the material.

CorTec plans to market the AirRay Cortical Electrode through distribution partners. Corresponding contracts are currently in preparation.

Learn more about °AirRay Cortical Electrode

Download the press release on the market clearance of °AirRay Cortical Electrode

 

[1] See the publication by S. Liu et al., Brain 2018, 1, doi:10.1093/brain/awx374

14.03.2019

Meet Us at IEEE Neural Engineering!

Meet us at the 9th International IEEE EMBS Conference on Neural Engineering focussing on “Neurotechnologies for Medical Therapies and Beyond” taking place from March 20-23 in San Francisco.
CTO and CEO, Dr. Martin Schüttler, will give a talk about ‘Focus on Neural interface and Electrode Technologies’ at the IEEE NeuroTech Entrepreneurship and Innovation Workshop on March 20th during Symposium#2: Neural Probes, Interface and Electrode, Orthopedics Technologies between 11am and 12:30pm.

21.02.2019

CorTec Is Chosen Innovator 2019 by brand eins and Statista

Just like last year CorTec has made it to the list of the most innovative companies selected by German business journal brand eins and Statista. Together with 16 other companies in the medical devices industry CorTec may now bear the title “Innovator 2019”.

Experts from the Institute for Innovation an Technology (iit) in Berlin and from the Statista panel „Expert Circle“ as well as leading business representatives from innovation award-winning companies have assessed more than 2,000 companies from 20 industries this year. Other companies in the “Medical Devices and Products” / “Medizinische Geräte und Produkte” industry that are acclaimed alongside CorTec are for example Otto Bock Healthcare, Medtronic, Siemens Healthcare, Heraeus or Med-El.

“The renewed distinction as one of the most innovative companies is a great honor for us, especially as it reflects the consistency in our development as a company over the last years,” said Dr. Jörn Rickert, Chief Executive Officer of CorTec. “After moving to our new facilities and bringing the human version of our Brain Interchange system into operation we still see high potential to boost our innovative capabilities,” added Dr. Martin Schüttler, Chief Technology Officer and Chief Executive Officer of CorTec. “We are just at the beginning.”

CorTec is positioning itself with its Brain Interchange technology as a partner for the development of innovative neurotherapies. First customers are using the closed-loop system already for pre-clinical research. The first human use of the system for exploring new personalized therapies for diseases like chronic pain, stroke, or Parkinson’s disease is about to follow as soon as possible.

CorTec is partnering up with researchers, clinicians, or other companies providing knowhow and technology to enable the development of next generation neuortherapies.

Learn more about the most innovative companies in Germany

Learn more about CorTec Brain Interchange

Neuere Artikel »